= Discovery stage.
= Translation stage.
= Clinically available.
MSACL 2018 EU : Rappold

MSACL 2018 EU Abstract

Self-Classified Topic Area(s): Practical Training

2/3 Getting Lower Limits of Quantification in LC-MS/MS assays : Phases and Stages

Brian Rappold
Laboratory Corporation of America


Warning: Undefined variable $headshot in /var/www/html/view_abstract/view_abstract_in_program.php on line 704
 Brian Rappold (Presenter)
LabCorp

Presenter Bio: Brian Rappold is the Director of Mass Spectrometry for LabCorp. He's participated in MSACL EU since its inception, leading workshops and teaching short courses related to method development and validation strategies.

Relevant Financial Disclosures (within past 24 months, reported on Apr 09, 2026)
Honorarium/Expenses MSACL
Committee/Board/Advisory Board Metabolomic Diagnostics
Stock/Bonds LabCorp
Salary LabCorp

Abstract

The second of 3 lectures on improving instrument response will focus on the approaches and experimentation used in LC-MS/MS assays. Understanding that increased response can only be generated in two phases of the LC-MS/MS process (material loaded into the system and ionization cross-section), a series of examples on scientifically defining “optimization” will be walked through.